Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer ; volume:15 ; number:1 ; day:1 ; month:5 ; year:2017 ; pages:1-16 ; date:12.2017
Journal of translational medicine ; 15, Heft 1 (1.5.2017), 1-16, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Chen, Ina
- Beteiligte Personen und Organisationen
-
Mathews-Greiner, Lesley
Li, Dandan
Abisoye-Ogunniyan, Abisola
RAY, SATYAJIT
Bian, Yansong
Shukla, Vivek
Zhang, Xiaohu
Guha, Raj
Thomas, Craig
Gryder, Berkley
Zacharia, Athina
Beane, Joal D.
Ravichandran, Sarangan
Ferrer, Marc
Rudloff, Udo
SpringerLink (Online service)
- DOI
-
10.1186/s12967-017-1197-5
- URN
-
urn:nbn:de:1111-201705121480
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Ina
- Mathews-Greiner, Lesley
- Li, Dandan
- Abisoye-Ogunniyan, Abisola
- RAY, SATYAJIT
- Bian, Yansong
- Shukla, Vivek
- Zhang, Xiaohu
- Guha, Raj
- Thomas, Craig
- Gryder, Berkley
- Zacharia, Athina
- Beane, Joal D.
- Ravichandran, Sarangan
- Ferrer, Marc
- Rudloff, Udo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin–EGFR crosstalk
Building Information Modeling Supporting LEED Sustainability Certification – Streamlining the Required Documentation with BIM Tools
MIR194-2HG, a miRNA host gene activated by HNF4A, inhibits gastric cancer by regulating microRNA biogenesis
Tissue metabolic profiling of human gastric cancer assessed by 1H NMR
A novel TGFbeta/TGILR axis mediates crosstalk between cancer-associated fibroblasts and tumor cells to drive gastric cancer progression
Serine protease PRSS56, a novel cancer-testis antigen activated by DNA hypomethylation, promotes colorectal and gastric cancer progression via PI3K/AKT axis
lncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1
LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex
Gastric cancer
Gastric cancer
Affibody-based molecular probe 99m Tc-(HE) 3 Z HER2:V2 for non-invasive HER2 detection in ovarian and breast cancer xenografts
Gastric Cancer: A Practical Review on Management of Individuals with Hereditary or Familial Risk for Gastric Cancer
Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin–EGFR crosstalk
Building Information Modeling Supporting LEED Sustainability Certification – Streamlining the Required Documentation with BIM Tools
MIR194-2HG, a miRNA host gene activated by HNF4A, inhibits gastric cancer by regulating microRNA biogenesis
Tissue metabolic profiling of human gastric cancer assessed by 1H NMR
A novel TGFbeta/TGILR axis mediates crosstalk between cancer-associated fibroblasts and tumor cells to drive gastric cancer progression
Serine protease PRSS56, a novel cancer-testis antigen activated by DNA hypomethylation, promotes colorectal and gastric cancer progression via PI3K/AKT axis
lncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1
LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex
Gastric cancer
Gastric cancer
Affibody-based molecular probe 99m Tc-(HE) 3 Z HER2:V2 for non-invasive HER2 detection in ovarian and breast cancer xenografts
Gastric Cancer: A Practical Review on Management of Individuals with Hereditary or Familial Risk for Gastric Cancer
Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin–EGFR crosstalk
Building Information Modeling Supporting LEED Sustainability Certification – Streamlining the Required Documentation with BIM Tools
MIR194-2HG, a miRNA host gene activated by HNF4A, inhibits gastric cancer by regulating microRNA biogenesis
Tissue metabolic profiling of human gastric cancer assessed by 1H NMR
A novel TGFbeta/TGILR axis mediates crosstalk between cancer-associated fibroblasts and tumor cells to drive gastric cancer progression
Serine protease PRSS56, a novel cancer-testis antigen activated by DNA hypomethylation, promotes colorectal and gastric cancer progression via PI3K/AKT axis
lncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1
LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex
Gastric cancer
Gastric cancer
Affibody-based molecular probe 99m Tc-(HE) 3 Z HER2:V2 for non-invasive HER2 detection in ovarian and breast cancer xenografts